tradingkey.logo
tradingkey.logo
検索

サブラ・ヘルスケア・リート(SBRA)2026年第3四半期決算説明会:SHOPの成長とガイダンス上方修正

Nov 3, 2026 11:44 PM
facebooktwitterlinkedin
すべてのコメントを見る(0)

セイブラ・ヘルスケア・リートの2026年第3四半期決算は、ノーマライズドFFOが前年同期比8%増の0.39ドル、AFFOが同8%増の0.41ドルとなり、業績予想の中間値を上方修正した。シニア住宅運営ポートフォリオ(SHOP)が成長を牽引し、既存物件のキャッシュNOIは14.6%増、入居率は89.2%へ上昇した。経営陣は7億4,700万ドル超の投資を完了し、2027年末までにSHOP比率を50%近くへ引き上げる方針を維持している。純負債倍率は4.54倍に低下し、手元流動性は約12億ドルと強固な財務基盤を維持している。

AI生成要約

主要なポイント

  • セイブラ・ヘルスケア・リート(Sabra Health Care REIT)が発表した2026年第3四半期のノーマライズドFFOは1株当たり0.39ドル、ノーマライズドAFFOは1株当たり0.41ドルとなり、ともに前年同期比8%増加しました。
  • 既存物件(Same-store)SHOPのキャッシュNOI(純営業利益)は前年同期比14.6%増加し、キャッシュNOIマージンは34.9%に達しました。入居率は160ベースポイント上昇し、89.2%となりました。
  • 同社は年初来で推定利回り8%となる7億4,700万ドル超の投資を完了しました。また、4億2,500万ドルの内定投資案件を抱えるほか、さらに2億6,000万ドルのSHOP案件を積極的に推進しています。
  • 経営陣は2026年のノーマライズドFFOおよびAFFOの業績予想中間値を1株当たり0.05ドル引き上げました。改定後の中間値に基づく前年比成長率の見通しは、ノーマライズドFFOが7%、ノーマライズドAFFOが8%となっています。
  • 調整後EBITDAに対する純負債倍率は、前四半期の4.61倍から4.54倍へと低下しました。2026年9月30日時点の手元流動性は約12億ドルに達しています。
  • 経営陣は、ポートフォリオの分散を維持し、賃料改定による潜在的な増益機会を活用するため専門看護施設への投資も維持しつつ、SHOPの比率が2027年末までに50%近くに達すると見込んでいます。

主要財務データ

指標2026年第3四半期前年同期比/補足
1株当たりノーマライズドFFO0.39ドル第2四半期の0.38ドルから上昇、前年同期比8%増
1株当たりノーマライズドAFFO0.41ドル第2四半期の0.40ドルから上昇、前年同期比8%増
キャッシュベース賃貸収入9,350万ドル1,020万ドルの繰延賃料支払いを除く
SHOPキャッシュNOI4,840万ドル第2四半期の4,460万ドルから増加
既存物件SHOPキャッシュNOI成長率14.6%前年同期比
既存物件SHOPキャッシュNOIマージン34.9%経営陣により業界トップクラスと説明
既存物件SHOP入居率89.2%前年同期比160ベースポイント上昇
既存物件SHOP売上高成長率9.3%前年同期比
既存物件SHOP RevPAR成長率7.3%前年同期比
既存物件SHOP ExPOR増加率4.7%人件費の伸びは3%未満に抑制
純負債/調整後EBITDA4.54倍2026年6月30日時点の4.61倍から低下
手元流動性約12億ドル2026年9月30日時点
四半期配当1株当たり0.30ドル第3四半期の1株当たりノーマライズドAFFOの73%

事業および業績の動向

セイブラのシニア住宅運営ポートフォリオ(SHOP)が引き続き主な成長ドライバーとなりました。未安定化施設および持分法適用合弁事業の同社持分を含めると、前四半期比で売上高は10.3%増、NOIは8.5%増となりました。

米国における既存物件SHOPの入居率は211ベースポイント上昇して86.9%となりました。カナダの入居率は77ベースポイント上昇して93.9%となり、10四半期連続で90%を超えました。カナダの既存物件売上高およびRevPARは、それぞれ7.0%増、6.4%増となりました。

費用の増加は主に修繕維持費、販売促進費、インセンティブ管理手数料によるものです。人件費の伸びは3%未満にとどまりました。経営陣は、入居者料金の好調な推移について、運営会社がより高度な介護ニーズを持つ入居者に対応し、それに応じた介護レベルの料金を請求していることも一因であるとしています。

セイブラは第3四半期中に2億2,280万ドルを投資し、7つのSHOP施設を追加しました。四半期末以降もさらに1億4,070万ドルを投資して4つのSHOP施設を取得しました。年初来の投資額は7億4,700万ドルを超え、推定利回りは8%となっています。

同社は完了済みおよび内定済みの投資案件が11億7,000万ドル超あり、そのほぼすべてがSHOPに特化しています。さらに2億6,000万ドルのSHOP投資案件を推進中です。年初以降に完了した取引の約30%は相対取引(オフマーケット)であり、完了済み・内定済み案件の65%では既存の運営会社が引き続き運営を担当する見込みです。

専門看護施設においては、経営陣が2つのポートフォリオ最適化案件の交渉を進めています。該当するリース・カバレッジ・レシオは2倍を超えており、2027年から2031年にかけてのリース満了に伴い賃料増額の可能性があると経営陣は見込んでいます。アバミア(Avamere)の移行により、10月1日付けで年間換算賃料が4,800万ドルから5,300万ドルに増加し、経営陣は2027年に前年比で約500万ドルまたはそれをやや上回るNOI貢献を見込んでいます。

経営陣による業績予想

セイブラは2026年のノーマライズドFFOおよびノーマライズドAFFOの業績予想中間値を1株当たり0.05ドル引き上げました。改定後の中間値に基づくと、1株当たりノーマライズドFFOの成長率は前年比7%、1株当たりノーマライズドAFFOの成長率は同8%となる見通しです。

経営陣は、第4四半期のSHOPの見通しが強化された背景として、ポートフォリオ全体の堅調さと予測精度の向上を挙げました。同社は営業レバレッジに支えられ、入居率と料金の持続的な成長を期待しています。経営陣は、追加の入居率上昇が現在少なくとも50%のマージン・フロースルーを生み出しており、入居率が92%〜93%に達すると70%超まで上昇する可能性があると試算しています。

4億2,500万ドルの内定投資パイプラインについては、経済条件は2026年に完了した取引と同様の水準を維持しています。経営陣はアンレバードIRR(内部収益率)が10%台前半から10%台半ばの範囲になると示唆しました。一部のバリューアップ投資を含め、完了済みおよび内定済みのパイプライン全体における初年度の期待利回りは7%台前半となっています。

セイブラは、既存の手元資金、信用枠の借入可能額、およびATM(At-The-Market)株式発行による調達資金により、2027年第1四半期または第2四半期前半までの計画投資資金を賄えると考えています。今後の取引では約30%〜35%の負債を利用し、残額は利益剰余金または増資により調達する見込みです。

リスクおよび注視事項

2026年を通じてシニア住宅のキャップレート(還元利回り)は圧力を受けましたが、金利上昇に伴いその圧力は和らいだと経営陣は述べています。セイブラはキャップレートの縮小(評価上昇)や拡大(評価下落)を想定せず、現在の市場水準で売却時キャップレート(Exit Cap Rate)の引受審査を行っています。

バリューアップ型SHOP投資には、運用実行や業績安定化に関する検討事項が伴います。経営陣は、最近取得したバリューアップ資産の入居率およびNOIは当初の審査想定を上回って推移しているものの、まだプロセスとしては初期段階にあると注記しました。

SHOPの営業費用は、修繕費、マーケティング費、および経営管理インセンティブ費用により増加しました。また、セイブラが築年数の古い物件を取得した場合、時間の経過とともに資本的支出(CapEx)の必要性が高まる可能性があります。同社が最近取得した物件の築年数は概ね10年未満です。

潜在的な医療政策の変更により、人員配置基準や医療施設への民間投資に関する議論が再燃する可能性があります。経営陣は、日常の事業運営への影響よりもメディアの話題となるにとどまると予想しており、セイブラのポートフォリオ全体として以前提案された連邦の人員配置基準をすでに満たしていると説明しました。

アナリスト質疑応答のハイライト

  • SHOPのポートフォリオ構成: 経営陣はSHOPの比率に固定の上限を設けていません。2027年末までにSHOPの比率が50%近くに達すると見込んでいますが、シニア住宅と専門看護施設の間で分散を維持する方針です。
  • 物件取得時の引受審査: 安定時の想定入居率は、地域市場に応じて概ね92%〜93.5%の範囲となっています。足元の料金成長率の想定は、引き続き5%前後(1桁台半ば)を維持しています。
  • 価格決定力: 堅調な料金成長は入居率90%超の施設に限られません。セイブラは、入居率が80%台の物件でも平均を上回る料金成長を確認しています。
  • 専門看護施設の最適化: 賃料に関連する2つの交渉案件が進められており、合意に至れば2027年に通年またはほぼ通年での寄与が見込まれます。
  • 資産売却: 経営陣は現在、専門看護施設の重要な売却を想定していません。ポートフォリオの整理・選別は継続されますが、資産売却が占める資金調達上の割合は引き続き比較的低水準にとどまる見通しです。
  • SHOPの資本的支出: 経営陣は、物件の築年数に応じて、1室あたり年間約1,200ドル〜1,500ドルの経常的資本支出が一般的な目安であると言及しました。

決算説明会トランスクリプト全文


決算説明会の完全なトランスクリプト

経営陣による説明

Operator

Good day, everyone. My name is Percy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sabra Health Care REIT Third Quarter 2026 Earnings Call. [Operator Instructions]

I would now like to turn the call over to Lukas Hartwich, EVP, Finance. Please go ahead, Mr. Hartwich.

Lukas Hartwich

Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our earnings guidance for 2026 and our expectations regarding our tenants and operators and our expectations regarding our acquisition, disposition and investment plans. These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2025, as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday.

We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid. In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the Financials page of the Investors section of our website at sabrahealth.com. Our Form 10-Q, earnings release and supplement can also be accessed in the Investors section of our website.

And with that, let me turn the call over to Rick Matros, CEO, President and Chair of Sabra Health Care REIT.

Rick Matros

Thanks, Lucas, and thanks, everybody, for joining us this morning. Our same-store SHOP cash NOI margins were 34.9%, which is best-in-class. Our RevPOR growth was stellar again for the quarter, along with solid cash NOI growth and occupancy increasing. We've closed on $750 million in investments to date, all of which is SHOP except for $100 million, which was skilled nursing. We have $425 million awarded and expect more to come before year-end. All of that but $24 million is SHOP. Our skilled nursing and senior housing triple net rent coverage continues to get better. As we continue to move forward towards 40% SHOP exposure going to 50% by year-end 2027, our senior housing portfolio will outweigh our skilled portfolio for the first time as that exposure drifts closer to 40%. We see no barriers that would prevent this momentum from continuing. That said, we believe it's important to have that diversity in the portfolio. As we have demonstrated, our skilled portfolio offers more earnings growth than the 2.5% escalators that we have seen historically. Our focus on optimizing rents was evident in our July announcement, and we are currently assessing other opportunities.

Additionally, as you look to our lease expirations, we expect to see rent increases in those portfolios as rents get reset to fair market given how much higher than fair market rent coverages currently are. The strategic focus that we've had will result in 7% to 8% year-over-year earnings growth at the midpoint of guidance this year. Certainly a mark we feel good about and bodes well for that portfolio's contribution to future earnings.

With that, I'll turn it over to Darrin.

Darrin Smith

Thank you, Rick. Sabra's senior housing operating portfolio had another great quarter with continued growth. The total senior housing operating portfolio, including non-stabilized communities and joint venture assets that share had sequential revenue growth of 10.3% and NOI growth of 8.5%. These statistics demonstrate sequential improvement in operating results that reflect our SHOPs continued growth and strong performance.

During the third quarter, Sabra invested $222.8 million, adding 7 SHOP communities to Sabra's portfolio. Subsequent to quarter end, Sabra invested an additional $140.7 million, adding 4 SHOP communities, bringing total year-to-date investments to over $747 million with an estimated yield of 8%. Additionally, Sabra has another $425 million of additional awarded investments, nearly all SHOP which should close in the near future. In addition to the over $1.17 billion in closed and awarded investments, Sabra has an additional $260 million of SHOP investments that we are actively pursuing.

On a year-over-year basis, Sabra added 18 SHOP communities, an 18% increase by number of assets and over 60% increase in total SHOP NOI. Deal flow shows no signs of slowing and Sabra remains competitive on new investments.

Moving on to the same-store portfolio. Sabra's same-store SHOP portfolio, including joint venture assets at share, continued its strong performance in the third quarter. The key numbers are: Revenue for the quarter grew 9.3% year-over-year with our Canadian communities growing revenue by 7% in the same period. Third quarter occupancy in our same-store portfolio was up 160 basis points to 89.2% year-over-year. Notably, our domestic portfolio occupancy increased 211 basis points to 86.9% during that period, while our Canadian portfolio grew 77 basis points to 93.9% in the same period, marking the 10th consecutive quarter where occupancy was over 90%. RevPAR in the third quarter continued to rise with an increase of 7.3% year-over-year with our Canadian portfolio increasing 6.4% in the same period.

While RevPOR and occupancy continue to grow, ExPOR increased 4.7% for the same period, providing for cash NOI growth of 14.6% on a year-over-year basis. The increase in ExPOR was driven primarily by repairs and maintenance, sales and marketing and incentive management fees, while labor continues to grow less than 3%. With over $1.17 billion in closed and award investments to date, a very robust pipeline and industry tailwinds at our backs, we should continue to see solid growth in our portfolio.

And with that, I will turn the call over to Michael Costa, Sabra's Chief Financial Officer.

Michael Costa

Thanks, Darrin. For the third quarter of 2026, we recognized normalized FFO per share of $0.39 and normalized AFFO per share of $0.41 compared to $0.38 and $0.40, respectively, in the second quarter. Year-over-year, our third quarter normalized FFO per share and normalized AFFO per share each posted an increase of 8%. Cash rental income from our triple net portfolio increased $1.2 million on a normalized basis compared to the second quarter.

Cash rental income was $93.5 million for the quarter, excluding a $10.2 million payment of deferred rents received in the quarter. On a normalized basis, our second quarter cash rental income was $92.3 million after adjusting for $1.8 million of out-of-period revenues primarily related to the Avamere rent reset. SHOP cash NOI was $48.4 million this quarter compared to $44.6 million last quarter. This increase reflects both the contribution from recent investment activity, including 7 communities added during the quarter and continued same-store occupancy gains and rate growth.

Interest and other income was $3.2 million for the quarter compared to $5.8 million in the second quarter. The decrease was primarily due to repayments of loans in the second and third quarters. Cash interest expense was $26.8 million for the quarter compared to $27.4 million in the second quarter. The decrease reflects lower borrowings under our credit facility during the period. Normalized cash G&A was $10.6 million for the quarter compared to $10.7 million last quarter.

During the quarter, we wrote off $6.2 million of straight-line rent receivables and lease intangibles, primarily due to the transitioning of the former Avamere portfolio. This amount was normalized in our quarterly results. We have updated our 2026 earnings guidance and increased the midpoint of our per share normalized FFO and normalized AFFO by $0.05. At the midpoint, this represents year-over-year per share growth of 7% for normalized FFO and 8% for normalized AFFO.

Now briefly turning to the balance sheet. Our net debt to adjusted EBITDA ratio was 4.54x as of September 30, 2026, compared to 4.61x at June 30, 2026. As we have stated previously, our strategy is to naturally lower our leverage over time without sacrificing earnings growth. This quarter's results reflect that strategy in action, and it is a strategy we will continue to employ. As of September 30, 2026, we had approximately $1.2 billion of liquidity, and we're in compliance with all of our debt covenants.

In addition to $36.2 million of unrestricted cash and cash equivalents and $873.5 million of available borrowings under our revolving credit facility, we had $292.5 million related to shares outstanding under forward sales agreements under our ATM program, which consisted of 15 million shares at an initial weighted average price of $19.53 per share net of commissions. Additionally, we have $332.7 million of availability remaining under the ATM program.

During the quarter, we issued 6.5 million shares in settlement of certain outstanding forward sales agreements under our ATM program at a weighted average price of $17.89 per share, net of commissions, resulting in net proceeds of $116.2 million. These proceeds, together with cash on hand, were used to fund our investment activity during the quarter.

Finally, on November 2, 2026, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on November 30, 2026, to common stockholders of record as of the close of business on November 13, 2026. The dividend is well covered and represents a payout of 73% of our third quarter normalized AFFO per share.

And with that, we'll open up the lines for Q&A.

Operator

[Operator Instructions] Your first question comes from the line of Juan Sanabria with BMO Capital Markets.

質疑応答

Juan Sanabria

Just curious if you could, Rick or Darrin elaborate on the, optimization in skilled nursing and maybe that includes the behavioral hospitals. Is that just rent increases upon expiration, which you touched on in the prepared remarks? Does that include further potential sales or monetizations of the assets to accelerate this transition towards SHOP NOI?

Rick Matros

Juan, thanks. So it's just skilled nursing. And there are a couple that we're currently working on. One is another transition similar to the ones that we talked about in July. And the other is a lease that's coming up in the not-too-distant future and the operators involved are interested in negotiating an extension sooner or later, and that extension would carry with it an increase in rents simply given where rent coverage is for that portfolio today and what we would normally put a new lease at for a skilled nursing operator, somewhere around 1.5%. So that's really where the upside is. And if you look at our lease expiration schedule, we've got between 2027 and 2031, we have a big chunk of leases coming up. So you should expect us to take advantage of that in the same way that we've been taking advantage of to date and again, for the same reasons. So does that answer your question, Juan?

Juan Sanabria

It does. And then just as a follow-up, if I may. Just curious if you can give a little bit more color on the fourth quarter-to-date transactions and the $400-plus million that's in process that has been agreed to in pricing and how that may have been -- how that may be changing kind of the initial and longer-term yield expectations on those acquisitions?

Rick Matros

What was the first part of the question, Juan, say again?

Juan Sanabria

The recent deals, what's closed fourth quarter to date and what's kind of pending to close and how cap rates have trended?

Darrin Smith

Sure. So this is Darrin. Economics in the current pipeline for $425 million are similar to those completed in 2026. It's a mix of stable assets and some modest value-add or upside opportunities. Unlevered IRRs continue to range in the low double digits to mid-teens. I would say that the previously closed assets had more SNF and pref equity, some higher-yielding investments. That being said, there's definitely been cap rate pressure on the senior housing side that we've seen in the industry throughout the year. However, with the rising interest rates, that pressure appears to have moderated for now.

Operator

Your next question comes from the line of Jamie Feldman with Wells Fargo.

James Feldman

I guess along the same lines, how have you changed your underwriting assumptions with higher rates and then just with operating conditions in the business in terms of your willingness to underwrite better NOI growth or maybe weaker NOI growth and then exit cap rates as you're thinking about your own IRR outlooks?

Darrin Smith

Sure. So each -- the underwriting of each investment opportunity is very asset market specific, number one. Occupancy, we're still keeping occupancy or stabilized occupancy probably up to the 92%, maybe 93.5% range, once again, depending upon the local market. As far as rate growth is concerned, you do end up with a little bit more visibility into near-term rate growth that typically takes place January 1 as these plans are kind of implemented here later in the year. So those tend to be -- at least they have tended to be kind of in the mid-single digits for now. But as far as exit cap rates, we are basically using what we see as a cap rate -- market cap rate today. So there's no sort of cap rate compression or inflation.

Rick Matros

Yes. And we'll also -- and as we had mentioned earlier or last call or whatever, we are looking at doing more value add, and we did do a sizable value add. And when we say value add, we're not talking about operations that are destabilized. We're looking at 80% occupancy in the case of the deal that we did. That obviously brings down the overall yield, but it provides a lot more upside for us going forward. So given the volume of deal flow that we have and that we anticipate having next year, we can do those kinds of things here and there and still make it work for us with our cost of capital.

James Feldman

Okay. And then turning to Avamere. Can you just remind us how much rent remains to commence and the incremental '27 contribution that's not yet reflected in the current or current run rate?

Michael Costa

Sure. So when we did that transition effective October 1, that took the annualized rent from $48 million to $53 million. So we're only seeing the impact of that on 2026 numbers just for 3 months. That full impact is going to be seen in 2027, obviously. And actually, the increase year-over-year will be slightly higher than that because, as you recall, we did the rent reset earlier in the year. So you should expect to see year-over-year the NOI generated from that lease to be, call it, $5 million or a little bit higher than $5 million on a year-over-year basis.

James Feldman

Okay. But it sounds like it's in the full 4Q run rate?

Michael Costa

It is in the full 4Q run rate. Yes, it's in our guidance.

Operator

Your next question comes from the line of Farrell Granath with Bank of America.

Andrew Reale

This is Andrew Reale on with Farrell. I guess, first, just with respect to the SHOP same-store NOI guide, what sort of improved in the fourth quarter outlook to support moving the guide up to the mid-teens? Is that mainly stronger occupancy and rate trends? Or are you expecting some expense growth to moderate as well?

Rick Matros

So, it's just overall strength in the performance of the SHOP portfolio.

Darrin Smith

Yes. And I think more visibility, right, because we're talking about 2 months of forecasting here versus 9 months earlier in the year.

Andrew Reale

Okay. Maybe one on the supplement. It looks like it now shows an estimated yield figure instead of initial cash yield in the investments. Also looks like 1Q SHOP deals moved from 7.9% yield to about 9.2%. Just curious what's behind the change and what is the new yield measuring?

Darrin Smith

I mean in terms of what the new yield is measuring, I think the simplest way to put it is it's a year 1 yield other than the situations -- the limited situations like Rick articulated, where we're doing some value-add opportunities, in which case we're using a stabilized yield on that. And when we say stabilized, we're talking about, call it, year 2 once the operator is able to go in and put their strategy in place. So it's, by and large, a year 1 yield except for those select opportunities. The one thing I would say is when you kind of take a step back and you look at our total closed and awarded pipeline, the going-in yield, the year 1 yield that we're expecting is in the low 7. So even with those value-add opportunities, the going-in yield that we're expecting in year 1 is still competitive with our cost of capital.

Rick Matros

And was that the other?

Darrin Smith

Yes. And your second part of the question, can you repeat that?

Andrew Reale

No, I think you answered it. Just wondering what's behind the change, what is the measure, but I think you answered the question.

Operator

Your next question comes from the line of Austin Wurschmidt with KeyBanc Capital Markets.

Austin Wurschmidt

Great. Just going back to the earlier question about the optimization of skilled nursing. You highlighted those 2 opportunities. Can you give us a sense of just to quantify what that upside opportunity looks like from an NOI perspective and really the timing of those taking place and how much they could contribute to '27, I guess?

Rick Matros

Not yet, we can because we're still in the process of negotiating that. And -- but I would expect that there'll be a full 2027 year impact or pretty close to it. So -- but we're just -- we're still in the process of negotiating those.

Darrin Smith

Yes. And to the extent those are completed by the time we release our fourth quarter earnings and our 2027 guidance, those will obviously be reflected in there as well.

Rick Matros

If there's a reason to do an update, say again?

Austin Wurschmidt

No, I was just going to say, is there -- could you give us a sense where the coverage ratios are for those specific leases today?

Rick Matros

They're well over 2x.

Austin Wurschmidt

Got it. And then you mentioned some SNF and preferred equity deals that you did subsequent to the third quarter. Are you seeing a larger number of skilled nursing investment opportunities? And is that something that's of interest to you to mix in with some of the SHOP investments in the awarded pipeline?

Rick Matros

No, not at all. These are off-market deals. We're not seeing any uptick in sort of traditional down the fairway triple net skilled deals. So -- and then on the prep, the prep all relates to the development that we're doing on the senior housing side with existing operating partners. And one of the reasons it works for us, where as in almost every development deal that we look at, they don't pencil. In the instances that we're doing deals, one, they're with operators that have their own in-house capabilities. Very often, they go land for a while, so the basis is low. So they're really distinct opportunities as opposed to kind of the beginnings of any trend on the development side.

Austin Wurschmidt

That's helpful data.

Rick Matros

Yes. And also, we may not wait until fourth quarter earnings to -- on the optimization stuff if we have something that we can just do a business update on before then.

Operator

Your next question comes from the line of Michael Stroyeck with Green Street.

Michael Stroyeck

Can you just talk a bit about the behavioral health business? Where is coverage for that portfolio? How did that change this quarter? And maybe any color on the kind of the near-term outlook for that business would be helpful.

Rick Matros

So all we really have left, we're pretty much out of the substance abuse disorder business. We have Signature left, which is 5 site hospitals. So it's actually quite a different business. They've been a tenant since 2017. And so now they sit more -- without the substance abuse disorder business, that business fits much more aligned with our other category, which includes rehab hospitals and some acute hospitals and a couple of other things that are more specialized in nature. So the coverage, it's a much more dynamic business as is the acute hospital business. So you're going to see occupancy and coverages go up and down a little bit, but the coverage is really strong in that other category in total is closer to 4x and 3x. So we feel like we're in pretty good shape there.

In terms of the future of our relationship with Signature, as we've said in the past, this is not -- it's not RCA. They've been a reliable tenant for a long time. They'd like to own the real estate, but it's got to be compelling for us. We can't -- we're not going to -- we're not willing to take dilution to earnings in order to get a deal done there. So for right now, I'd say they'll continue to be our tenant. And that other category is now down to 10% of the total portfolio and will continue to shrink as we grow the rest of the business. So it becomes less and less impactful.

Michael Stroyeck

Got it. That's helpful. And then maybe can you provide some color on the coverage stratification you guys started disclosing this quarter? What segments or operators make up that 1 to 1.5x bucket? And are there any concerns that rent cuts could be needed on any of those assets?

Darrin Smith

No, there's no concerns that any rent cuts are needed. And I would say those buckets, it's a mix of skilled nursing and senior housing that's in there.

Operator

Your next question comes from the line of Wes Golladay with Baird.

Wesley Golladay

I just want to get a little bit more color on the deferred cash rent payment of over $10 million this quarter. Is that a sign of a tenant getting healthy and going back to accrual accounting?

Darrin Smith

That's actually a sign of, yes, getting healthier, but then also a transition that happened with that particular operator. And as part of that transition as part of us agreeing to that transition, combined with their stronger financial position today, we require that they repay that deferred rent, and they gladly did to make that transaction happen.

Wesley Golladay

Okay. Going to the senior housing, is the RevPAR growth broad-based? It's pretty strong, over 7%. And what is driving that? Is it just pricing power the concession burn off? Is it mix at all? Just trying to get a little bit more details on that.

Darrin Smith

Yes, it's interesting because we get the question, others get the question as well regarding pricing power. Are you going to be able to increase rates above market when you're above 90% occupancy. And while that intuitively makes sense, we're not seeing any evidence of that within our portfolio, at least not yet. There are some facilities that are over 90% occupancy that are be able to push higher rates, but we have some that are in the 80s that are be able to push higher rates as well. I think probably the one thing that we would probably chalk up the strong RevPOR growth to most significantly is acuity. And the ability of a lot of our operators to increase -- take on higher acuity residents and provide the care that they need and be able to charge those levels of care accordingly, that's having a positive contribution on the RevPOR side.

Operator

Your next question comes from the line of Vikram Malhotra with Mizuho.

Vikram Malhotra

I guess just maybe first one, Rick, you talked about the trajectory of SHOP. You went from 20 to 40 now pro forma, I guess, 50. I'm just wondering like where do you see this ultimately shaking out? Meaning, at what point do you say like we've had enough SHOP growth. Now you just referenced cap rates coming in, perhaps taking more value add. So you have like a good balance. You have these rent resets all adding to growth next year. By just my math, you should be at least 6%, 7% FFO growth with everything you've done. So I'm just wondering, bigger picture, like how big do you grow the SHOP platform? And how much more risk do you take in terms of value add?

Rick Matros

Well, I think we don't view ourselves taking risk on value add. It's funny how everything changes. Now that people are thinking about occupancy in the 90s, all of a sudden 80%, which is actually quite stabilized. It's viewed as not stabilized. But if you're at 80%, you've got a good operator in there and a good asset, there's not much risk there. So we'd like to do more of that. In terms of our SHOP exposure overall, our focus is on growing earnings, and we're going to follow where the opportunities are. So right now, the predominant opportunities are in SHOP, and that's why we're anticipating 12 months out, we'll be closer to 50% SHOP and closer to 40% skilled nursing. We're happy to do more skilled nursing, and we can do both. So if the SHOP opportunities remain what they are and there are more skilled nursing opportunities, we're just going to do both. So we're not sort of putting any parameters on how much SHOP we want to have or how much skilled nursing we want to have. We want to have a very well-balanced portfolio. We like the idea of having more SHOP than skilled. But as we all know, for those of us that are -- have been around for a pretty long time, the outlook is great for both SHOP and skilled. But life happens and stuff happens, and we just don't want to have everything. We don't want to make a bet just on one asset class only, particularly with the contributions that we're getting out of the skilled portfolio now. And as I mentioned earlier, if you look at our lease expiration schedule, we're going to have outsized contributions from our skilled portfolio through the end of the expiration -- the lease expiration schedule in 2031. So that's a good place, I think, for us to be. So does that answer your question, Vikram?

Vikram Malhotra

That's helpful. I guess just a bigger picture question. We'll see what the midterm outcome is today. But I'm wondering like are there any specific states you're watching from a -- is there any Medicaid growth implications or even bigger picture, like if there's a blue wave versus not, like any thoughts around what that may mean for skilled and the reimbursement landscape?

Rick Matros

Yes. Sure. So if the chambers are split with the Republicans holding the Senate and DEMS getting the House, I don't think there'll be much change if or much of a fight over anything. If the DEMS win both the Senate and the House, they've already put this paper together. It's like 81 pages on health care overall, and there's some stuff in there that we like with the workforce investments. And it's not just about long-term care, by the way, it's about the entire health care space. We would expect that there may be things coming up like staffing again or private investment in health care facilities. So that kind of stuff will bubble up again. When we beat those things down in the past, we did it with bipartisan support. Not everybody sees it that way on the DEM side. So we feel pretty comfortable with it. There'll be probably a little bit more noise about it if the DEMS win the Senate as well, I think, is probably the best way to put it.

The other thing I'd point out is -- to remind everybody, every state that we're in has staffing mandates currently. And that the, the staffing mandate that was originally recommended at the federal level was one that Sabra in the aggregate already met. So it's just not a concern. So I think it's going to be more noise and headlines than actual impact on the day-to-day business.

Vikram Malhotra

Okay. Great. And then, sorry, just if I can clarify one thing. Assuming this trajectory continues and you're headed to then pro forma, let's say, 60% SHOP, meaning in terms of acquisitions next year. Just remind us like capital available to fund incremental deals into 1Q '27? And then what your order of preference would be? Like would you be doing more disposition? Would you use leverage? Just remind us sort of the preference for funding all of this?

Michael Costa

Yes. I mean, in terms of financing, I think between our cash on hand, availability on our line of credit and what we've raised on the ATM, we have enough capital to close everything we need to close through early '27, call it, Q1 or even early Q2 of '27. And then going forward, I think when you look at investment opportunities that come our way, we would look to fund them similarly, use our credit facility to fund the debt portion of it, call it, 30% to 35% -- and the rest would come from either retained earnings or from raising equity in the ATM or even the traditional ways if there's enough volume to do so. From the disposition side, look, you're always going to have some level of dispositions. I think that's something every company should be doing and looking at their portfolio and pruning it off periodically. I wouldn't expect it to be of a meaningful volume. It's not going to be of a volume that's going to allow us to fund our existing -- our entire pipeline or anything like that, but it will be part of the equation, but albeit a small part of it.

Operator

Your next question comes from the line of Seth Bergey with Citi.

Seth Bergey

I guess I just wanted to go back to kind of the pipeline and how much of kind of the awarded pipeline is either off-market or from existing operators that are kind of already with you?

Darrin Smith

Sure. So the off-market transactions we've been doing through the beginning of the year, we've been averaging about 30% off-market. And then as far as existing operators, we're only changing operators in about 35% of the total closed and awarded opportunities. So 65% of the incumbent operator will be staying in place.

Rick Matros

And by the way, last year, we had almost no off-market deals, and we've intentionally developed relationships where we can do more off-market. So we jumped from about 0% to 30% just in the last year.

Seth Bergey

Great. And then maybe going back to some of your earlier comments around occupancy and 90%, how should we kind of think about kind of the operating leverage and the incremental margin flow-through as you kind of achieve higher occupancy within some of the more stabilized assets?

Rick Matros

So where occupancy currently is, you're going to see a minimum 50% pull-through to the margin. As you get to 92% and 93%, that's going to grow probably to 70-plus percent. There's just not that much more cost associated with bringing in just a few extra residents. So those are probably good numbers. But we've already -- to be clear, we've already surpassed the operating leverage mark. So that pull-through has already started to happen, which is really one of the reasons that we've got sector high cash NOI margins.

Operator

Your next question comes from the line of Dave Rogers with Raymond James.

David Rodgers

I think you addressed this maybe a couple of questions ago but maybe ask it in a different way. 40-some-odd percent of your skilled expirations are kind of after 2035. And I think Ensign has been out there desiring to buy some assets out of their REIT partner portfolios. I don't know if they've approached you or not, but how do you think about some of the long-dated SNF assets and maybe offloading some of those continue to accelerate the growth in the company overall, but keep some of the near-term opportunities that you mentioned earlier in the call?

Rick Matros

Yes. At this point, we feel like we've pretty much cleaned the portfolio of anything that we didn't want to retain on the skilled side. So we'll see what the environment looks like. But as we sit here today, I wouldn't anticipate any material dispositions with our skilled operators. I mean the space has such a nice runway ahead of it. But the environment may change over the next couple of years. We've got time, obviously, to make those judgments. We're not having those conversations with anybody right now kind of to answer your question about that with Ensign. So we'll see. We'll be open-minded about it.

David Rodgers

And then just a quick follow-up on the leased senior housing portfolio. Any opportunities there as well for rent resets, transitions to manage anything like that, that would benefit you as well?

Rick Matros

We've pretty much done as much as can be done there. If there's any other opportunity, it's going to be incremental. So basically, that piece of the portfolio, which is down to about 7% of our NOI right now are legacy operators that like everybody else kind of went through hell during the pandemic. They're doing really well now. They're good operators. And so they're content with where things are. We're happy to have them as operators. We're not going to force them out of the portfolio just because they're triple net. So you're just going to see that number continue to shrink as a percent.

Operator

Your next question comes from the line of Juan Sanabria with BMO Capital Markets.

Juan Sanabria

Just curious on the SHOP side of the business, how you're thinking about costs as a result of your tech and data initiatives and how you think about export trending from here?

Michael Costa

So in terms of the costs that we're incurring at the corporate side, I mean, I think it's really incremental in the grand scheme of things. We're making investments today. We have a lot of the infrastructure already in place, adding to it incrementally, as I mentioned. So I don't see that as being anything that's going to meaningfully move the needle. From a cost perspective, obviously, from an efficiency perspective, we fully believe that to be the case on the corporate side as we continue to take on more operators, as we continue to expand that portfolio. The initiatives that are happening at the facility level, I think is more -- speaks more to your question in terms of export. Look, I think all those initiatives are done with an eye towards making operations more efficient, whether that's on the housekeeping side, whether that is on the caretaker side, whatever it may be, it's all with an eye towards improving the efficiency and the ultimate delivery of care there.

Juan Sanabria

And just one last one for me. There was a mention of kind of value-add investment opportunities. So just curious on how you guys think about CapEx for the SHOP business on a per unit per year basis, presumably those may be having some deferred CapEx. And any thoughts about why you guys don't include SHOP CapEx now that SHOP is 40% of the business in your FAD calc? I think most of the peers do that.

Michael Costa

I mean in terms of the FAD calc years ago, we decided we didn't want to put FAD in our supplement or anywhere else just because the SEC prohibits you from showing it on a per share basis. Now with that said, as we talked about before, the numbers are all there, right? We do disclose what our recurring CapEx is. We disclose what our nonrecurring CapEx. So the math is all there if somebody really wants to calculate what FAD is on an apples-to-apples basis with a competitor or a peer of ours, I should say. We just don't want to disclose it because we can't show it on a per share basis. That's simply it.

Rick Matros

And in terms of CapEx spending, right now, everything that we've been buying is less than 10 years old, including the value-add stuff. So there's not much in the way of meaningful CapEx spend. I think it's reasonable to assume as time goes by and the amount of newer assets kind of dwind us a little bit, you'll pick up some older assets and that will require more CapEx spend going forward.

Juan Sanabria

And then the rule of thumb, I guess, on how much you guys think is the appropriate amount to spend on a per unit per year basis?

Michael Costa

Yes. It depends on the age of the property, but it's, I guess, rule of thumb is around 1,200 to 1,500.

Operator

Your next question comes from the line of Michael Goldsmith with UBS.

Michael Goldsmith

Maybe sticking with value-add SHOP investments that you've already closed. Can you give us an update on how those assets are actually tracking relative to the original underwriting? And are you still comfortable with that 1 to 2-year stabilization time line and roughly 9% stabilized yield?

Michael Costa

Yes. So the -- they are actually performing ahead of underwriting and projections, both from an occupancy perspective and an NOI. So it's still early days, but so far, so good.

Michael Goldsmith

Got it. And then just to clarify the comment made earlier, I think, around that when you get to 90% occupancy, you get pricing power and you're not seeing it. Are you -- was the purpose of that comment to suggest that you're seeing pricing power before you hit 90% occupancy? Just wanted to clarify that.

Michael Costa

I mean the comment was more directly around the 7-plus percent RevPOR growth we saw this quarter wasn't because our portfolio is over 90%. We're seeing facilities that have occupancy in the 80s being able to drive higher-than-average rate growth, right? So it's not directly correlated today. It's not directly correlated with being over some occupancy threshold. That's it.

Rick Matros

Right. So once you get into the lower 90s, I think is an intuitive assumption. It seems that everybody's part that there will be pricing power. And there may be, we're not saying there won't be. We're just not there yet on occupancy. So the fact that our RevPOR has been as strong as it's been, it's not just this quarter, by the way, without that bodes really well going forward.

Operator

Your next question comes from the line of Austin Wurschmidt with KeyBanc Capital Markets.

Austin Wurschmidt

I just wanted to go back to something discussed on the first quarter call around the landmark assets that were intended to be sold. Where does that stand? Has anything been completed on that front? I'm just looking for a general update.

Rick Matros

Yes. Thanks for that stuff has gone. There's a couple left that are dwindling out, and that's kind of rounding.

Operator

There are no further questions at this time. I would now turn the call back to Rick Matros for closing remarks.

Rick Matros

Thanks for your time today. I appreciate your continued support, and we look forward to seeing a lot of you at NAREIT in a few weeks. Take care.

Operator

This concludes today's call. Thank you for attending. You may now disconnect.

この記事の一部はAIによって生成・翻訳され、人間によるレビューを経ています。これは一般的な情報提供の目的でのみ使用されており、投資アドバイスを構成するものではありません。

免責事項:本サイトで提供する情報は教育・情報提供を目的としたものであり、金融・投資アドバイスとして解釈されるべきではありません。

コメント (0)

$ボタンをクリックし、シンボルを入力して、株式、ETF、またはその他のティッカーシンボルをリンクします。

0/500
コメントガイドライン
読み込み中...

おすすめ記事

tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。